TR200103473T2 - Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları. - Google Patents

Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları.

Info

Publication number
TR200103473T2
TR200103473T2 TR2001/03473T TR200103473T TR200103473T2 TR 200103473 T2 TR200103473 T2 TR 200103473T2 TR 2001/03473 T TR2001/03473 T TR 2001/03473T TR 200103473 T TR200103473 T TR 200103473T TR 200103473 T2 TR200103473 T2 TR 200103473T2
Authority
TR
Turkey
Prior art keywords
octane
amine
citratin
polymorphs
pharmaceutical compositions
Prior art date
Application number
TR2001/03473T
Other languages
English (en)
Inventor
James Castaldi Michael
Joseph Quallich George
Theophilus Wint Lewin
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Publication of TR200103473T2 publication Critical patent/TR200103473T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Tek bir kristalli poliformik form (2S,3S)-N(metoksi-5-t-butilfenil-metil-2- difenilmetil-1-azobisiklo (2.2.2) oktan-3-amin sitrat(sitrat monohidrat) ve bunun farmasötik kompozisyonu.Sitrat monohidratin polimorfik formunun farmasötik kompozisyonu, emez tedavi amaçli formülasyon için avantajli bir kararliliga sahiptir. Bu farmasötik kompozisyonun verilmesi, aninda birakmali oral dozaj formu, tercihen tablet veya kapsül ile veya venöz içinedir.
TR2001/03473T 1999-06-01 2000-05-18 Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları. TR200103473T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13699299P 1999-06-01 1999-06-01

Publications (1)

Publication Number Publication Date
TR200103473T2 true TR200103473T2 (tr) 2002-04-22

Family

ID=22475338

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2001/03473T TR200103473T2 (tr) 1999-06-01 2000-05-18 Kristalli azabisiklo (2.2.2) oktan-3-amin sitratin polimorfları ve farmasötik kompozisyonları.

Country Status (48)

Country Link
US (1) US6255320B1 (tr)
EP (1) EP1181290B1 (tr)
JP (1) JP3830816B2 (tr)
KR (1) KR100476606B1 (tr)
CN (1) CN1146565C (tr)
AP (1) AP2001002349A0 (tr)
AR (1) AR033331A1 (tr)
AT (1) ATE244239T1 (tr)
AU (1) AU767334B2 (tr)
BG (1) BG65240B1 (tr)
BR (1) BR0011094A (tr)
CA (1) CA2372238C (tr)
CO (1) CO5170463A1 (tr)
CY (1) CY2007011I1 (tr)
CZ (1) CZ295819B6 (tr)
DE (1) DE60003679T2 (tr)
DK (1) DK1181290T3 (tr)
DZ (1) DZ3050A1 (tr)
EA (1) EA003731B1 (tr)
EC (1) ECSP003508A (tr)
EE (1) EE200100656A (tr)
ES (1) ES2199825T3 (tr)
GT (1) GT200000087A (tr)
HN (1) HN2000000077A (tr)
HR (1) HRP20010904A2 (tr)
HU (1) HUP0201301A3 (tr)
IL (1) IL146406A0 (tr)
MA (1) MA26742A1 (tr)
MX (1) MXPA01012325A (tr)
MY (1) MY133508A (tr)
NO (1) NO20015848L (tr)
NZ (1) NZ515349A (tr)
OA (1) OA11956A (tr)
PA (1) PA8496101A1 (tr)
PE (1) PE20010209A1 (tr)
PL (1) PL196046B1 (tr)
PT (1) PT1181290E (tr)
SI (1) SI1181290T1 (tr)
SK (1) SK285820B6 (tr)
SV (1) SV2001000093A (tr)
TN (1) TNSN00120A1 (tr)
TR (1) TR200103473T2 (tr)
TW (1) TWI285204B (tr)
UA (1) UA66925C2 (tr)
UY (1) UY26176A1 (tr)
WO (1) WO2000073304A1 (tr)
YU (1) YU81101A (tr)
ZA (1) ZA200109775B (tr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0507325A (pt) * 2004-01-30 2007-07-03 Pfizer Prod Inc antagonistas dos receptores nk-1 para melhorar a recuperação da anestesia
EP1713506A1 (en) * 2004-01-30 2006-10-25 Pfizer Products Incorporated Pharmaceutical compositions of neurokinin receptor antagonists and cyclodextrin and methods for improved injection site toleration
HUE034099T2 (en) * 2004-01-30 2018-01-29 Zoetis Services Llc Antimicrobial preservatives for the delivery of multidose formulations using beta-cyclodextrins for liquid dosage forms
DK1713801T3 (da) * 2004-02-02 2008-03-17 Pfizer Prod Inc Fremgangsmåde til fremstilling af 1-(2S,3S)-2-benzhydryl-N-(5-tert-butyl-2-methoxybenzyl)quinuclidin-3-amin
JP6454323B2 (ja) * 2013-03-15 2019-01-16 パール セラピューティクス，インコーポレイテッド 粒子状結晶性材料のコンディショニングのための方法及びシステム
CN110577522B (zh) * 2018-06-07 2022-12-27 东莞市东阳光动物保健药品有限公司 马罗匹坦柠檬酸盐新晶型及其制备方法
CN112979639B (zh) * 2019-12-16 2025-08-08 凯默斯医药科技(上海)有限公司 一种马罗皮坦新晶型及其制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR9206073A (pt) * 1991-05-31 1994-12-06 Pfizer Derivados de quinuclidina
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
US5576317A (en) * 1994-12-09 1996-11-19 Pfizer Inc. NK-1 receptor antagonists and 5HT3 receptor antagonists for the treatment of emesis

Also Published As

Publication number Publication date
CA2372238C (en) 2006-12-19
UY26176A1 (es) 2000-12-29
DE60003679D1 (de) 2003-08-07
AU767334B2 (en) 2003-11-06
HK1046284A1 (en) 2003-01-03
KR100476606B1 (ko) 2005-03-18
DE60003679T2 (de) 2004-05-27
YU81101A (sh) 2004-07-15
NO20015848D0 (no) 2001-11-30
HN2000000077A (es) 2001-02-02
EP1181290A1 (en) 2002-02-27
PE20010209A1 (es) 2001-03-01
CN1353711A (zh) 2002-06-12
WO2000073304A1 (en) 2000-12-07
IL146406A0 (en) 2002-07-25
BG65240B1 (bg) 2007-09-28
ECSP003508A (es) 2002-02-25
DZ3050A1 (fr) 2004-03-27
BG106204A (en) 2002-07-31
DK1181290T3 (da) 2003-09-29
TWI285204B (en) 2007-08-11
CN1146565C (zh) 2004-04-21
OA11956A (en) 2006-04-13
MY133508A (en) 2007-11-30
UA66925C2 (uk) 2004-06-15
PT1181290E (pt) 2003-09-30
SI1181290T1 (en) 2003-12-31
SV2001000093A (es) 2001-11-08
AP2001002349A0 (en) 2001-12-31
PL352716A1 (en) 2003-09-08
JP2003501354A (ja) 2003-01-14
ES2199825T3 (es) 2004-03-01
SK285820B6 (sk) 2007-09-06
TNSN00120A1 (fr) 2005-11-10
CZ20014269A3 (cs) 2002-04-17
EA200101108A1 (ru) 2002-04-25
HUP0201301A3 (en) 2002-10-28
HUP0201301A2 (en) 2002-08-28
NO20015848L (no) 2001-12-18
US6255320B1 (en) 2001-07-03
KR20020010688A (ko) 2002-02-04
ZA200109775B (en) 2002-11-28
CZ295819B6 (cs) 2005-11-16
AR033331A1 (es) 2003-12-17
NZ515349A (en) 2004-03-26
MA26742A1 (fr) 2004-12-20
PL196046B1 (pl) 2007-11-30
AU4424800A (en) 2000-12-18
CY2007011I2 (el) 2010-07-28
EE200100656A (et) 2003-02-17
CY2007011I1 (el) 2010-07-28
HRP20010904A2 (en) 2003-02-28
CO5170463A1 (es) 2002-06-27
JP3830816B2 (ja) 2006-10-11
PA8496101A1 (es) 2002-07-30
EP1181290B1 (en) 2003-07-02
GT200000087A (es) 2001-11-22
CA2372238A1 (en) 2000-12-07
MXPA01012325A (es) 2002-07-22
BR0011094A (pt) 2002-03-19
ATE244239T1 (de) 2003-07-15
SK17332001A3 (sk) 2002-07-02
EA003731B1 (ru) 2003-08-28

Similar Documents

Publication Publication Date Title
DE60142891D1 (de) Azetidinderivate enthaltende pharmazeutische zusammensetzungen, die azetidinderivate und deren herstellung
FI872864A0 (fi) Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi
AR035320A1 (es) Compuestos activadores de hppardelta, composicion farmaceutica, su uso en la preparacion de medicamentos, metodo para el tratamiento de enfermedades mediadas por hppardelta
SE8804629D0 (sv) New therapeutically active compounds
PL315636A1 (en) Cosmetic or pharmaceutic compositions containing magnipherine or its derivatives
NO20022014D0 (no) Kontrollert frigjöring av hydrocodone formuleringer
ATE359777T1 (de) Fenofibratsäure enthaltende pharmazeutische zusammensetzung und deren physiologisch verträgliche salze und derivate
UA85359C2 (ru) Таблетка, содержащая гранулированный материал с kmd-3213
DE50203456D1 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
NO894616D0 (no) Fremgangsmaate for fremstilling av anti-aterosklerotisk aktive diarylforbindelser.
ATE268174T1 (de) Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen
FI891865A0 (fi) Laekemedel som innehaoller azelastin med kontrollerad frigoering av det verksamma aemnet.
IL92799A0 (en) Benzimidazole derivatives with gastric acid inhibition and process for its preparation
ATE13488T1 (de) Gallium-chlorid, ein neues antikrebsmittel.
MY133508A (en) Polymorphs of a crystalline azobicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions
TW200517127A (en) Novel composition
SE9901572D0 (sv) New compounds
NO950177L (no) Farmakologisk aktive erivater
ATE302010T1 (de) Pharmazeutische zusammensetzung, enthaltend desoxypeganin zur behandlung des alkoholismus
MD940244A (ro) Derivaţi noi ai tetrazolului, procedeu de obţinere a lor şi compoziţie farmaceutică pe baza lor